428
Views
5
CrossRef citations to date
0
Altmetric
Original Research

Safety and immunogenicity of chromatographically purified Vero cell rabies vaccine for intradermal pre- and post-exposure rabies prophylaxis

, , , , , , , & show all

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Piyada Angsuwatcharakon, Sumana Khomvilai, Kornvika Limsuwun, Natchaya Ratananpinit, Apinya Khamchat, Teeranit Sanitnai & Terapong Tantawichien. (2018) Immunogenicity and safety of WHO-approved TRC-ID regimen with a chromatographically purified Vero cell rabies vaccine with or without rabies immunoglobulin in children. Expert Review of Vaccines 17:2, pages 185-188.
Read now

Articles from other publishers (4)

Thomas Moulenat, Céline Petit, Valérie Bosch Castells & Guy Houillon. (2020) Purified Vero Cell Rabies Vaccine (PVRV, Verorab®): A Systematic Review of Intradermal Use Between 1985 and 2019. Tropical Medicine and Infectious Disease 5:1, pages 40.
Crossref
Martine Denis, Ivana Knezevic, Henry Wilde, Thiravat Hemachudha, Deborah Briggs & Lea Knopf. (2019) An overview of the immunogenicity and effectiveness of current human rabies vaccines administered by intradermal route. Vaccine 37, pages A99-A106.
Crossref
Annefleur C Langedijk, Cornelis A De Pijper, Rene Spijker, Rebecca Holman, Martin P Grobusch & Cornelis Stijnis. (2018) Rabies Antibody Response After Booster Immunization: A Systematic Review and Meta-analysis. Clinical Infectious Diseases 67:12, pages 1932-1947.
Crossref
Anuradha Bose, Renuka Munshi, Radha Madhab Tripathy, Shampur N. Madhusudana, B.R. Harish, Saket Thaker, B.J. Mahendra, Bhagwat Gunale, Nithya J. Gogtay, Urmila M. Thatte, Reeta Subramaniam Mani, K. Manjunath, Kuryan George, Ashwin Belludi Yajaman, Ashish Sahai, Rajeev M. Dhere, Reginald G. Alex, Debasis Das Adhikari, Abhilash, Venkata Raghava, Dipti Kumbhar, Tapas Ranjan Behera & Prasad S. Kulkarni. (2016) A randomized non-inferiority clinical study to assess post-exposure prophylaxis by a new purified vero cell rabies vaccine (Rabivax-S) administered by intramuscular and intradermal routes. Vaccine 34:40, pages 4820-4826.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.